BBH

VanEck Biotech ETF
*Unless otherwise stated, data provided by FactSet.

BBH Fund Description

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.

BBH Factset Analytics Insight

BBH offers a more concentrated take on the global biotech industry. Although the space is already dominated by US firms, the fund aims to select just 25 US listed companies by market cap, also weighing each constituent by market cap. The underlying index has a flexible definition of biotech, encompassing companies engaged primarily in research (including research contractors) and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment, excluding pharmacies. Also, despite capping its issuers to a maximum of 20%, the fund may still be top heavy due to the index’s concentrated nature. Overall, BBH is a viable take on this market. The index is reviewed semi-annually.

PERFORMANCE [as of 06/29/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
BBH -3.12% -- -22.49% -27.15% 4.73% 3.43% 12.37%
BBH (NAV) -3.34% -11.40% -22.54% -27.26% 4.60% 3.41% 12.36%
MVIS US Listed Biotech 25 Index -- -- -- -- -- -- --
MSCI AC World IMI / Biotechnology -IND -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

BBH Summary Data

VanEck
12/20/11
Open-Ended Fund
0.35%
$440.77M
$4.17M
0.11%

BBH Portfolio Data

$48.96B
22.82
4.85
0.27%
12/19/22
25

BBH Index Data

Market Cap
Market Cap
MSCI AC World IMI / Biotechnology -IND

BBH Portfolio Management

0.35%
-0.32%
-0.21%
-0.41%

BBH Tax Exposures

20.00% / 39.60%
0.04%
Qualified dividends
No

BBH Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

BBH Factset Analytics Block Liquidity

As of 06/30/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BBH. BBH is rated a 5 out of 5.

BBH Tradability

29,165
$4.17M
24,183
$3.62M
0.11%
$0.16
0.00%
0.19% / -0.90%
None
96.00%
25,000
0.97
0.00%
0.10%
55
$146.60
5

BBH Sector/Industry Breakdown


BBH
Segment Benchmark
90.27%
--
6.81%
--
2.97%
--
-0.05%
--

BBH Top 10 Holdings[View All]

Amgen Inc. 13.44%
Seagen, Inc. 5.66%
Biogen Inc. 4.54%
ICON Plc 4.31%
63.97%

BBH Countries


BBH
Segment Benchmark
92.01%
--
4.46%
--
3.53%
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

BBH Regions


BBH
Segment Benchmark
92.01%
--
4.46%
--
3.53%
--
--
--

BBH Economic Development


BBH
Segment Benchmark
100.00%
--
--
--

BBH Performance Statistics

--
--
--
--
--
MSCI AC World IMI / Biotechnology -IND

BBH Benchmark Comparison Holdings

25
--
--
--

BBH Benchmark Comparison Summary


BBH
Segment Benchmark
25
--
$48.96B
--
22.82
--
4.85
--
0.79%
--
High
--

BBH Benchmark Comparison Market Cap Size


BBH
Segment Benchmark
85.19%
--
14.81%
--
0.00%
--
0.00%
--